Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Int J Pharm ; 572: 118783, 2019 Dec 15.
Article de Anglais | MEDLINE | ID: mdl-31678393

RÉSUMÉ

The purpose of this study was to develop a novel gastroretentive drug delivery system with immediate buoyancy and high wet strength. The proposed bilayer tablet was composed of a drug layer and a highly porous and swellable gastroretentive (GR) layer. The highly porous GR layer was prepared by sublimating the volatile materials after compaction with swellable polymers. This pore-forming process decreased the density of the GR layer and enabled the tablet to float immediately on the dissolution media. The GR layer formulation was optimized by comparing the swelling, erosion, and mechanical properties of candidate swellable polymers. The release rates were conveniently controlled by changing the polymer content in the drug layer, while the swelling and floating properties were provided by the GR layer. The application of percolation theory revealed that the polymer content above the estimated threshold was required for a reliable drug release profile. In vivo study in fed beagle dogs confirmed the enhanced gastric retention time of the tablets compared to that of conventional single layer tablets. Taken together, our data suggest that the proposed system can be a promising platform technology with superior GR properties and a convenient formulation process.


Sujet(s)
Vecteurs de médicaments , Antihistaminiques des récepteurs H2/administration et posologie , Polymères/composition chimique , Ranitidine/administration et posologie , Administration par voie orale , Animaux , Chiens , Préparation de médicament , Libération de médicament , Absorption gastrique , Vidange gastrique , Antihistaminiques des récepteurs H2/composition chimique , Antihistaminiques des récepteurs H2/pharmacocinétique , Mâle , Porosité , Période post-prandiale , Ranitidine/composition chimique , Ranitidine/pharmacocinétique , Solubilité , Comprimés
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE